Get the Stockscreener App
2.26
0.00%
0.01
Pulmatrix Inc stock is traded at $2.26, with a volume of 20,613.
It is up +0.00% in the last 24 hours and down -44.36% over the past month.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
See More
Previous Close:
$2.27
Open:
$2.29
24h Volume:
20,613
Relative Volume:
1.17
Market Cap:
$8.29M
Revenue:
$11.68M
Net Income/Loss:
$-8.85M
P/E Ratio:
-0.9378
EPS:
-2.41
Net Cash Flow:
$-14.61M
1W Performance:
+4.13%
1M Performance:
-44.36%
6M Performance:
-65.24%
1Y Performance:
-63.91%
1-Day Range:
$2.26
$2.35
1-Week Range:
$2.146
$2.3599
52-Week Range:
$2.146
$10.40
Pulmatrix Inc Stock (PULM) Company Profile
Name
Pulmatrix Inc
Sector
Industry
Phone
(888) 355-4440
Address
945 CONCORD STREET, FRAMINGHAM, MA
Compare PULM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PULM
Pulmatrix Inc
|
2.27 | 8.29M | 11.68M | -8.85M | -14.61M | -2.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.92 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
773.55 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
405.75 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
801.69 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.75 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Pulmatrix Inc Stock (PULM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-18 | Initiated | H.C. Wainwright | Buy |
Pulmatrix Inc Stock (PULM) Latest News
Financial Review: Pulmatrix (NASDAQ:PULM) and Onconetix (NASDAQ:ONCO) - Defense World
Behavioral Patterns of PULM and Institutional Flows - Stock Traders Daily
Is Pulmatrix Inc. (2PU) stock among top earnings playsWeekly Risk Summary & Smart Allocation Stock Tips - Улправда
Decliners Report: Will Pulmatrix Inc. stock split attract more investors2025 Sector Review & Real-Time Volume Triggers - moha.gov.vn
Why Pulmatrix Inc. (2PU) stock remains stableEntry Point & Reliable Price Breakout Alerts - Улправда
Will Pulmatrix Inc. (2PU) stock outperform foreign stocks2025 Key Lessons & Verified Stock Trade Ideas - Улправда
Why Pulmatrix Inc. stock remains a top recommendationJuly 2025 Closing Moves & Weekly Sector Rotation Insights - Улправда
Why analysts upgrade Pulmatrix Inc. stockEarnings Recap Summary & Weekly Watchlist for Hot Stocks - Улправда
Shorts Report: Is Pulmatrix Inc. (2PU) stock among top earnings playsJuly 2025 Sentiment & Risk Controlled Daily Plans - Улправда
Whale Trades: Is Pulmatrix Inc. (2PU) stock worth buying before Fed actionMarket Sentiment Report & Weekly Chart Analysis and Guides - Улправда
Is Pulmatrix Inc. stock attractive for passive investorsQuarterly Trade Summary & Free Low Drawdown Momentum Trade Ideas - DonanımHaber
Is Pulmatrix Inc. (2PU) stock worth buying before Fed actionWeekly Investment Report & Momentum Based Trading Signals - Улправда
Will Pulmatrix Inc. stock outperform Nasdaq indexJuly 2025 Patterns & Long-Term Capital Growth Strategies - DonanımHaber
Can Pulmatrix Inc. stock resist market sell offsJuly 2025 Pullbacks & Risk Managed Investment Entry Signals - Улправда
ulpravda ru > 2025> Will Pulmatrix Inc. stock maintain growth storyIPO Watch & Verified Technical Signals - Улправда
GNI Subsidiary Cullgen and Pulmatrix Relax Merger Terms to Seek Strategic Alternatives - TipRanks
Pulmatrix and Cullgen waive exclusivity while awaiting China approval By Investing.com - Investing.com Nigeria
Pulmatrix and Cullgen Modify Merger Terms - citybiz
Pulmatrix and Cullgen continue to pursue merger - marketscreener.com
Pulmatrix (PULM) Adjusts Merger Agreement with Cullgen, Explores New Options - GuruFocus
Pulmatrix and Cullgen Suspend No-Solicitation to Seek Alternatives - TipRanks
Pulmatrix and Cullgen waive exclusivity while awaiting China approval - Investing.com
Pulmatrix, Inc. Announces Waiver Agreement in Merger with Cullgen - TradingView — Track All Markets
Pulmatrix (NASDAQ: PULM) waives Section 5.4 in Cullgen merger pact - Stock Titan
Pulmatrix and Cullgen Continue to Pursue Merger While Granting Each Other Waivers to Explore Alternatives - PR Newswire
Surprises Report: What sentiment indicators say about Pulmatrix Inc stockPortfolio Growth Summary & Community Verified Watchlist Alerts - moha.gov.vn
Liquidity Mapping Around (PULM) Price Events - Stock Traders Daily
Pulmatrix Earnings Notes - Trefis
Gains Report: Will Pulmatrix Inc stock maintain momentum in 2025Weekly Stock Recap & Capital Efficiency Focused Strategies - moha.gov.vn
Income Plays: What insider trading reveals about Pulmatrix Inc stockJuly 2025 Earnings & Weekly High Return Stock Forecasts - moha.gov.vn
Aug Gainers: How big funds are accumulating Vistra Corp 0V6 stockCPI Data & Safe Swing Trade Setup Alerts - BỘ NỘI VỤ
Pulmatrix Charts New Course Through Strategic Merger and Asset Divestment - AD HOC NEWS
How Pulmatrix Inc. stock benefits from strong dollar2025 Trading Recap & Intraday High Probability Alerts - Newser
How Pulmatrix Inc. (2PU) stock responds to bond marketJuly 2025 Technicals & Daily Stock Momentum Reports - Newser
Can Pulmatrix Inc. stock attract ESG capital inflowsMarket Performance Recap & AI Driven Stock Price Forecasts - Newser
Why institutional investors increase stakes in Pulmatrix Inc. (2PU) stockMarket Risk Analysis & High Return Stock Watch Alerts - Newser
How Pulmatrix Inc. (2PU) stock trades after earningsQuarterly Earnings Summary & Detailed Earnings Play Strategies - Newser
Why Pulmatrix Inc. (2PU) stock is a must watch tickerQuarterly Portfolio Report & Precise Entry and Exit Recommendations - Newser
Can Pulmatrix Inc. (2PU) stock deliver double digit returnsAnalyst Upgrade & Safe Entry Zone Tips - Newser
What market sentiment indicators show for Pulmatrix Inc. (2PU) stockWeekly Market Report & AI Forecasted Entry/Exit Points - Newser
Will Pulmatrix Inc. stock maintain dividend yieldMarket Sentiment Report & Weekly Setup with High ROI Potential - Newser
Is Pulmatrix Inc. (2PU) stock undervalued by metrics2025 AllTime Highs & High Accuracy Swing Trade Signals - Newser
Will Pulmatrix Inc. (2PU) stock see valuation expansionForecast Cut & Daily Profit Focused Screening - Newser
Is Pulmatrix Inc 2PU stock worth buying before Fed action2025 Market WrapUp & AI Enhanced Trading Signals - BỘ NỘI VỤ
Can Pulmatrix Inc. (2PU) stock retain market dominancePortfolio Value Report & Risk Controlled Swing Alerts - Newser
Is Pulmatrix Inc. stock a buy for dividend growthMarket Movement Recap & Community Driven Trade Alerts - Newser
Will Pulmatrix Inc. (2PU) stock benefit from Fed rate cutsWeekly Trend Summary & AI Based Trade Execution Alerts - Newser
KLTR Stock Analysis and ForecastEarnings Per Share Trends & AI-Driven Stock Forecast Models - earlytimes.in
Pulmatrix Inc Stock (PULM) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.45%
0.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):